Patient-derived BRAFV600E melanoma cells could grow without serum and exogenous growth factors, FGF2, EGF (epidermal growth factor), and HGF (hepatocyte growth factor), for at least 4 months without substantial changes in viability and cell phenotype. This evidence concerns the gene HGF and melanoma.